Osmotica pharmaceuticals plc (OSMT)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Sep'17
Revenues

231,554

240,031

245,815

246,699

261,026

263,701

0

0

0

0

Cost of goods sold (inclusive of amortization of intangibles)

103,017

111,630

128,646

134,690

135,723

140,082

0

0

0

0

Gross profit

128,537

128,401

117,169

112,008

125,302

123,619

0

0

0

0

Selling, general and administrative expenses

92,550

93,030

94,873

87,573

78,737

74,243

0

0

0

0

Research and development expenses

28,243

32,319

36,096

39,776

43,282

43,693

0

0

0

0

Impairment of intangibles

-

-

0

0

-

-

0

-

-

0

Impairment of goodwill

-

-

0

-

-

-

-

-

-

-

Total operating expenses

404,540

409,096

482,896

357,336

226,240

222,157

0

0

0

0

Operating loss

-276,003

-280,695

-365,727

-245,327

-100,937

-98,538

0

0

0

0

Interest expense and amortization of debt discount

17,774

18,211

18,950

19,758

20,447

20,790

0

0

0

0

Other non-operating (income) loss, net

-

-

-

-

-

-

-

-

0

0

Other non-operating expense

1,073

884

5,345

5,602

5,926

664

0

0

0

0

Total other non-operating expense (gain)

-16,701

-17,327

-17,714

-18,319

0

-

0

0

-

-

Loss before income taxes

-292,704

-298,022

-384,175

-264,326

-120,302

-118,664

0

0

0

0

Income tax benefit

-25,407

-27,121

-32,774

-22,023

-8,541

-8,983

0

0

0

0

Net loss

-267,297

-270,901

-351,401

-242,302

-111,760

-109,681

0

0

0

0

Other comprehensive loss, net
Change in foreign currency translation adjustments

-

-

0

-

-

-1,213

0

0

0

0

Comprehensive loss

-

-271,284

-351,758

-242,425

-112,605

-110,894

0

0

0

0

Income (loss) per share attributable to shareholders
Loss per share attributable to shareholders, basic and diluted

-0.05

-0.52

-2.15

-2.37

-0.13

-2.37

-0.08

0.14

-0.11

-

Partnership income (loss) per unit

-

-

-

-

-0.13

-

0.09

-

-

-12.27

Diluted

-

-

-

-

-

-

-

-

-

-12.27

Weighted average shares basic and diluted
Weighted average shares, basic and diluted

58,257

51,955

52,476

52,518

52,518

52,531

42,862

42,855

42,855

-

Weighted average partnership units

-

-

-

-

-

-

42,862

-

-

-

Basic and Diluted

-

-

-

-

-

-

-

-

-

1,000

Product Revenue
Revenues

226,380

235,472

241,790

243,193

258,963

261,398

0

0

0

-

Royalty Revenue
Revenues

3,789

3,641

3,129

2,707

1,717

1,959

0

0

0

-

Licensing and Contract Revenue
Revenues

1,385

918

895

798

345

344

0

0

0

-